GE HealthCare director buys and receives shares

GE HealthCare Technologies Inc. director Phoebe L. Yang Watkin reported acquiring additional common stock.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. director Phoebe L. Yang Watkin reported acquiring additional common stock. On May 8, 2026, she made an open-market purchase of 1,000 shares at a weighted average price of $63.0063 per share. After this trade, she directly held 13,702 shares.

On May 7, 2026, she also received an award of 3,586 restricted stock units. Each unit represents the right to receive one share of GE HealthCare common stock, with 100% of the units vesting on the earlier of the company’s next annual stockholders meeting or May 7, 2027, subject to the plan terms and any deferral elections.

Insider Trade Summary

Net Buyer: 1,000 shares

Net Buy 2 txns

Insider Yang Watkin Phoebe L.

Role Director

Bought 1,000 shs ($63K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.01 per share	1,000	$63.0063	$63K
Grant/Award	Common Stock, par value $0.01 per share	3,586	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 13,702 shares (Direct)

Footnotes (3)

1. F1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
2. F2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
3. F3. The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Key Figures

Open-market purchase: 1,000 shares at $63.0063/share Post-transaction holdings: 13,702 shares Restricted stock units granted: 3,586 RSUs +2 more

5 metrics

Open-market purchase 1,000 shares at $63.0063/share Common Stock purchased on May 8, 2026

Post-transaction holdings 13,702 shares Direct common stock position after May 8, 2026 trade

Restricted stock units granted 3,586 RSUs Award on May 7, 2026

RSU vesting date Earlier of next annual meeting or May 7, 2027 100% vesting condition for RSU award

Purchase price range $62.97–$63.01/share Price range for 1,000-share open-market purchase

Key Terms

restricted stock units, weighted average price, Non-Employee Director Compensation and Benefits Plan, grant, award, or other acquisition, +1 more

5 terms

restricted stock units financial

"Award of restricted stock units with respect to GE HealthCare Technologies Inc. common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"The price reported represents the weighted average price of shares purchased."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Non-Employee Director Compensation and Benefits Plan financial

"in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan."

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

open-market purchase financial

"transaction_action: open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GEHC director Phoebe L. Yang Watkin report?

She reported one open-market purchase of 1,000 GE HealthCare shares and an award of 3,586 restricted stock units. Both transactions increased her direct holdings, as disclosed in the Form 4 insider filing.

How many GEHC shares did the director buy on the open market?

She bought 1,000 shares of GE HealthCare common stock in an open-market transaction. The weighted average purchase price was $63.0063 per share, within a narrow range between $62.97 and $63.01.

What restricted stock unit grant did the GEHC director receive?

She received 3,586 restricted stock units tied to GE HealthCare common stock. Each unit represents one future share, with vesting conditions based on the next annual meeting or May 7, 2027, under the company’s director compensation plan.

When will the GEHC director’s restricted stock units vest?

All 3,586 restricted stock units will vest 100% on the earlier of GE HealthCare’s next annual stockholders meeting or May 7, 2027. Settlement may be deferred according to her elections under the director compensation plan.

How many GEHC shares does the director hold after these transactions?

Following the reported open-market purchase, she directly holds 13,702 shares of GE HealthCare common stock. This figure reflects her position after the May 8, 2026 acquisition disclosed in the Form 4.

What price range applied to the GEHC director’s share purchase?

The weighted average price was $63.0063 per share. The 1,000 purchased shares were bought in multiple trades at prices ranging from $62.97 to $63.01, as described in the filing footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 08:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yang Watkin Phoebe L.

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/07/2026		A		3,586(1)(2)	A	$0	12,702	D
Common Stock, par value $0.01 per share	05/08/2026		P		1,000	A	$63.0063(3)	13,702	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

3. The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)